Blepharitis is one of the most common ophthalmic conditions, characterised by chronic inflammation of the eyelid tissues and affecting the eyelashes, meibomian glands and ocular surface. Causative and
Dry eye disease is a common ocular surface disorder, resulting in one of the most frequently encountered complaints in ophthalmic practice. Whilst the disease is complex and multifactorial,
Success of endoscopic dacryocystorhinostomy with or without stents Maria Julia Orsolini, Silvana Artioli Schellini, Roberta Lilian Fernandes Souza Meneguim & Antônio José Maria Catâneo Orbit.
Uncorrected refractive errors account for up to 96% of visual impairment in school-aged children and are associated with amblyopia and strabismus development, and reduced performance in early literacy tests, reading ability and academic achievement. Amblyopia treatment is most effective before seven
CXL-assisted infection reduction: a randomised clinical trial evaluating the effect of adjuvant CXL on outcomes in fungal keratitis
Three-year observation of children, aged three to 10 with untreated intermittent exotropiaPediatric Eye Disease Investigator Group, Cotter SA et al. Ophthalmology 2019;126(9):1249-60Design: This study
The 2020 Ocular Therapeutics Conference (OTC) lived up to its name, providing interesting advice and discussion about new and old therapeutics for common and not so common ophthalmological conditions. Interest was maximised by the 15-minute, quick-fire presentation format from speakers knowledgeable
Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular oedema: a randomised clinical trial.
A 68-year-old man has been under my care for age-related macular degeneration (AMD). His right eye is under long-term anti-VEGF therapy for wet AMD. He has non-exudative (dry) AMD in his left eye and wanted to know if there was anything he could do to improve the outcome for his left eye. His visual
Myopia is rapidly emerging as one of the biggest public health concerns of our generaon. More than 2.5 billion people have myopia globally. It is esmated that by 2050 about half the world’s population will be at risk of losing their sight due to serious myopia-related complications, like retinal
Phase IIb clinical trials have begun to test the effects of an orally administered small molecule CCR3 inhibitor in wet AMD patients.
University of Munich scientists have developed a novel ink for consumer wearables that changes colour when exposed to ultraviolet (UV) light.
